Hypoxia preconditioning increases the ability of healthy but not diabetic rat-derived adipose stromal/stem cells (ASC) to improve histological lesions of streptozotocin-induced diabetic nephropathy-Reference-Cited by-同舟云学术

Hypoxia preconditioning increases the ability of healthy but not diabetic rat-derived adipose stromal/stem cells (ASC) to improve histological lesions of streptozotocin-induced diabetic nephropathy

Published:2022-02 Issue: Volume:230 Page:153756
ISSN:0344-0338
Container-title:Pathology - Research and Practice
language:en
Short-container-title:Pathology - Research and Practice

Author:

Carmona MDolores,Paco-Meza Luis-Miguel,Ortega Rosa,Cañadillas Sagrario,Caballero-Villarraso Javier,Blanco Alfonso,Herrera Concha

Funder

Instituto de Salud Carlos III

Ministerio de Ciencia e Innovación

Government of Spain Ministry of Science Innovation and Universities

Publisher

Elsevier BV

Subject

Cell Biology,Pathology and Forensic Medicine

Reference63 articles.

1. Paracrine effect of mesenchymal stem cell as a novel therapeutic strategy for diabetic nephropathy;Li;Life Sci.,2018

2. Diabetic nephropathy: time to withhold development and progression – a review;Sharaf El Din;J. Adv. Res.,2017

3. The role of bone marrow derived-mesenchymal stem cells in attenuation of kidney function in rats with diabetic nephropathy;Abdel Aziz;Diabetol. Metab. Syndr.,2014

4. Mesenchymal stem cells: a future experimental exploration for recession of diabetic nephropathy;Hamza;Ren. Fail.,2017

5. Diabetic nephropathy – complications and treatment;Lim;Int. J. Nephrol. Renov. Dis.,2014

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Therapeutic potential: The role of mesenchymal stem cells from diverse sources and their derived exosomes in diabetic nephropathy;Biomedicine & Pharmacotherapy;2024-06

2. Quantitative Proteomics Combined with Network Pharmacology Analysis Unveils the Biological Basis of Schisandrin B in Treating Diabetic Nephropathy;Combinatorial Chemistry & High Throughput Screening;2024-02

3. Efficacy of adipose‐derived mesenchymal stem cell therapy in the treatment of chronic micro‐ and macrovascular complications of diabetes;Diabetes, Obesity and Metabolism;2023-12-11

4. Injectable hypoxia-preconditioned cartilage progenitor cells-laden GelMA microspheres system for enhanced osteoarthritis treatment;Materials Today Bio;2023-06

5. Quantitative proteomics combined with network pharmacology analysis unveils the biological basis of Schisandrin B in treating diabetic nephropathy;2023-01-21